The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumTranscripts - Operator Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics conference call to present the positive Phase II results of … Continue Reading
Read nowInsights - Obesity data from big pharma competitors was presented at the American Diabetes Association conference this past weekend. The trend is moving towards developing oral GLP-1 … Continue Reading
Read nowTranscripts - Operator Good afternoon, and welcome to the Sarepta Therapeutics ELEVIDYS FDA accelerated approval call. [Operator Instructions] As a reminder, today’s program is being recorded. At … Continue Reading
Read nowTranscripts - Participants -Matt Gline, CEO -Mayukh, Sukhatme, President & CIO -Frank Torti, Chair Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to … Continue Reading
Read nowTranscripts - Participants Matt Kapusta, Chief Executive Officer Ricardo Dolmetsch, President of R&D Sara Tabrizi, KOL Maria Cantor, Chief Corporate Affairs Officer Maria Cantor, Chief Corporate Affairs Officer Good morning, … Continue Reading
Read nowResearch - Video Summary: Gossamer Bio (GOSS) will be reporting open label extension data in the coming weeks which could demonstrate that their inhaled seralutinib is a … Continue Reading
Read nowTranscripts - Participants Richard Aranda, CMO Fahim Hasnain, CEO Bryan Giruado, CFO Fahim Hasnain, CEO We’re very excited about getting our phase three off the ground. We’re … Continue Reading
Read now
